N. Dickgreber (Sarstedt, Germany), R.M. Huber (Munich, Germany), D. Jovanovic (Belgrade, Republic of Serbia)
Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases
J. Jareno Esteban, M. A. Munoz Lucas, B. Carrillo Aranda, J. A. Maldonado Sanz, C. Civera Tejuca, A. Aguilar Ros, G. Rodriguez Trigo, C. Gutierrez Ortega, J. L. Alvarez Sala, L. Callol Sanchez (Madrid, Spain)
|   |
Retrospective study of treatment outcomes according to exon difference with EGFR mutations in non-small cell lung cancer patient in Korea
H.S. Lee, J.S. Choi, K.H. Seo, J.O. Na, Y.H. Kim, M.H. Oh, S.S. Jou (Cheonan, Republic Of Korea)
| |
Clinical significance and functional roles of FoxM1 in non-small cell lung cancer
N. Xu, D. Jia, W. Chen, D. Ge, C. Bai (Shanghai, China)
| |
Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy
D. Yang, X. Wang, T. Zeng, J. Hu, Y. Song, L. Chen, X. Wang, C. Bai (Shanghai, China)
| |
Anti-tumorigenic effect of age-/diabetes-related advanced glycation end-products in lung carcinoma
B. Bartling, H.S. Hofmann, A. Sohst, V. Somoza, R.E. Silber, A. Simm (Halle (Saale), Regensburg, Germany; Vienna, Austria)
| |
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer
M. Petrovic, I. Cekerevac, G. Kostic, V. Iric Cupic, G. Davidovic, Z. Lazic, V. Cupurdija, L. Novkovic (Kragujevac, Republic Of Serbia)
| |
Clinical significance of serum osteopontin levels in lung cancer
A. Kazakou, T. Kerenidi, M. Lada, I. Tsilioni, E. Dalaveris, K. Gourgoulianis (Larissa, Greece)
| |
Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC)
E. Aynaci, E. Coskunpinar, A. Eren, O. Kum, Y. M. Oltulu, N. Akkaya, A. Turna, A. Aynaci, I. Yaylim, P. Yildiz (Istanbul, Turkey)
| |
Low levels of heme oxygenase-1 in induced sputum of lung cancer patients as a marker of defective cytoprotection
A. Bar-Shai, A. Ahimor, M. Stark, E. Fireman (Tel-Aviv, Israel)
| |
Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of lung cancer
S.L. Cheng (Tapiei, Taiwan)
| |
Epidermal growth factor receptor mutation status in advanced non-small cell lung cancer: A single institution experience
N. Vaguliene, M. Zemaitis, V. Sarauskas, A. Vitkauskiene, S. Miliauskas, R. Sakalauskas (Kaunas, Lithuania)
| |
Role of progestrin releasing peptide (ProGRP), a serum based biomarker in early diagnosis of SCLC in cohort of high-risk patient presenting with symptoms related to lung cancer
D. Yang, Y. Zhang, B. Pan, Y. Song, C. Bai (Shanghai, China)
| |
Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC)
F. Ghodrati, G. Ozkan, E. Aynaci, Y. Musteri Oltulu, E. Coskunpinar, P. Yildiz, I. Yaylim (Istanbul, Turkey)
| |
Lung cancer metabolomics in plasma, urine and broncheoalveolar lavage. A pilot study
R. Aguilar, E. Vázquez, A. Ruiz, R. Castilla, R. González, J. Grávalos, T. García, J. L. Gómez-Ariza, J. A. Maldonado, A. Pereira-Vega (Huelva, Spain)
| |
Increased levels of plasmatic dopamine in human small cell lung cancer
D. Scozzi, S. Mariotta, E. Cherubini, P. Bruno, L. Tabbì, F. Fioretti, A. Sciannamea, A. Piraino, V. Pietrangeli, A. Ricci (Rome, Italy)
| |
MAdL: A new diagnostic marker for adenocarcinomas
H. Schultz, S. Marwitz, B. Baron-Luehr, G. Zissel, C. Kugler, K. Rabe, P. Zabel, E. Vollmer, J. Gerdes, T. Goldmann (Borstel, Germany)
| |
Potential angiogenic biomarkers in patients with non small cell lung cancer: Possible implications
S. Abdel Ghani, N. Elmelegy, A. Mohamed-Hussein, R. Hanna (Assiut, Egypt)
| |
KI67: Analysis of its expression and prognostic significance in a resected non small cell lung cancer population
R. M. Diaz Campos, R. Garcia Lujan, E. de Miguel Poch, R. Alonso Moralejo, F. Lopez-Rios Moreno (Madrid, Spain)
| |
Increased activity of Lyn tyrosine kinase causes multiple chronic obstructive pulmonary disease-like changes in mouse
W. L. Lau, E. Duan, J. L. McQualter, G. P. Anderson, M. L. Hibbs (Melbourne, Australia)
| |
Genetic polymorphisms of k-ras gene in smoking related diseases
R. El-hefny, A. Shalaby, O. Shaker, Y. Akl, A. Al-halfawy, A. Elessawy (Fayoum, Cairo, Egypt)
| |